Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions. The tool, called EMBeddER (EMBER), ...

"Search" is our twice-yearly newsletter to supporters. In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Dr Luis Zapata Ortiz leads a dedicated research group focusing on advancing our understanding of the immune system's role in genetic variability and its implications for disease, cancer and ageing.

Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.